ライフサイエンスコーパス: Chlamydia trachomatis

1 a model for investigating the human pathogen Chlamydia trachomatis.

2 ted with the obligate intracellular bacteria Chlamydia trachomatis.

3 ant role of antibodies in protection against Chlamydia trachomatis.

4 ion with the obligate intracellular bacteria Chlamydia trachomatis.

5 -to-culture, obligate intracellular pathogen Chlamydia trachomatis.

6 re compared to Amplicor for detecting ocular Chlamydia trachomatis.

7 ysis of 52 geographically diverse strains of Chlamydia trachomatis.

8 ellular pathogens Listeria monocytogenes and Chlamydia trachomatis.

9 he obligate intracellular bacterial pathogen Chlamydia trachomatis.

10 uitous in many chlamydial species, including Chlamydia trachomatis.

11 lls for the obligate intracellular bacterium Chlamydia trachomatis.

12 fected with a single cervical inoculation of Chlamydia trachomatis.

13 is often found in the absence of detectable Chlamydia trachomatis.

14 t the major outer membrane protein (MOMP) of Chlamydia trachomatis.

15 xual transmission is probably lower than for Chlamydia trachomatis.

16 is triggered by diverse bacteria, including Chlamydia trachomatis, a frequent intracellular parasite

17 In the class I-c beta subunit from Chlamydia trachomatis, a heterodinuclear Mn(II)/Fe(II) c

18 Chlamydia trachomatis, a leading bacterial cause of sexu

19 Chlamydia trachomatis, a leading infectious cause of tub

20 Chlamydia trachomatis, a pathogen responsible for diseas

21 acid amplification tests (NAATs) that detect Chlamydia trachomatis AC2 also detects Neisseria gonorrh

22 ind that C. muridarum and the human pathogen Chlamydia trachomatis activate not only NLRP3 but also A

23 lesion, and changes in sexual behaviors and Chlamydia trachomatis, an infection with similar epidemi

24 is produced by chronic ocular infection with Chlamydia trachomatis, an obligate intracellular bacteri

25 (Versant CT/GC assay, where "CT" represents Chlamydia trachomatis and "GC" represents Neisseria gono

26 RealTime CT/NG assay (where "CT" stands for Chlamydia trachomatis and "NG" stands for Neisseria gono

27 iable analysis were vaccine status, positive Chlamydia trachomatis and >/=4 partners in the preceding

28 Lower genital tract infection with Chlamydia trachomatis and C. muridarum can induce long-l

29 Chlamydia trachomatis and Chlamydia muridarum are intrac

30 Plasmid-free Chlamydia trachomatis and Chlamydia muridarum fail to in

31 distinct steps in the polarized division of Chlamydia trachomatis and Chlamydia muridarum.

32 Chlamydia trachomatis and Mycoplasma genitalium coinfect

33 itive risk score had point-of-care tests for Chlamydia trachomatis and Neisseria gonorrhoea (nucleic

34 The next-generation amplification test for Chlamydia trachomatis and Neisseria gonorrhoeae (Roche c

35 se of infertility and ectopic pregnancy, and Chlamydia trachomatis and Neisseria gonorrhoeae are reco

36 Chlamydia trachomatis and Neisseria gonorrhoeae are the

37 Chlamydia trachomatis and Neisseria gonorrhoeae cases re

38 assay (ATV; Gen-Probe) and the prevalence of Chlamydia trachomatis and Neisseria gonorrhoeae coinfect

39 methods exist for the molecular detection of Chlamydia trachomatis and Neisseria gonorrhoeae in clini

40 ilable molecular assays for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae in recta

41 The assay simultaneously detects Chlamydia trachomatis and Neisseria gonorrhoeae in swab

42 with detectable T. vaginalis, codetection of Chlamydia trachomatis and Neisseria gonorrhoeae occurred

43 Patients were evaluated for Chlamydia trachomatis and Neisseria gonorrhoeae using NA

44 00/8800 systems (Cobas) for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae was esta

45 T) has become the preferred method to detect Chlamydia trachomatis and Neisseria gonorrhoeae, but no

46 ing (NAAT) is the preferred method to detect Chlamydia trachomatis and Neisseria gonorrhoeae, but no

47 isease associations, which parallel those of Chlamydia trachomatis and Neisseria gonorrhoeae, the mec

48 Tests for Chlamydia trachomatis and Neisseria gonorrhoeae, which c

49 of the two most common bacterial infections: Chlamydia trachomatis and Neisseria gonorrhoeae.

50 Chlamydia trachomatis and smoking are major risk factors

51 Female pig-tailed macaques inoculated with Chlamydia trachomatis and Trichomonas vaginalis (n = 9)

52 tigated whether coinfection of macaques with Chlamydia trachomatis and Trichomonas vaginalis decrease

53 ification testing for Neisseria gonorrhoeae, Chlamydia trachomatis, and Trichomonas vaginalis were pe

54 Although most individuals infected with Chlamydia trachomatis are initially asymptomatic, sympto

55 he obligate intracellular bacterial parasite Chlamydia trachomatis are the same as its eukaryotic hos

56 Neisseria gonorrhoeae and Chlamydia trachomatis are well-documented urethral patho

57 rs, how the obligate intracellular bacterium Chlamydia trachomatis arrives at a physiologically simil

58 urethritis (NGU) and cervicitis is aimed at Chlamydia trachomatis, but Mycoplasma genitalium, which

59 We recently detected PG in Chlamydia trachomatis by a new metabolic cell wall label

60 In both Chlamydia trachomatis (C. trachomatis) and C. pneumoniae

61 r screening adolescents and young adults for Chlamydia trachomatis (C. trachomatis) and Neisseria gon

62 female infertility and genital infection by Chlamydia trachomatis (C. trachomatis) is a major cause.

63 mation of the membrane of the human pathogen Chlamydia trachomatis (C.t.).

64 Chlamydia trachomatis can cause reproductive morbidities

65 Chlamydia trachomatis can enter a viable but nonculturab

66 Ocular infection with Chlamydia trachomatis can lead to trachoma, a leading in

67 Chlamydia trachomatis causes both trachoma and sexually

68 Chlamydia trachomatis causes chronic inflammatory diseas

69 Chlamydia trachomatis causes sexually transmitted infect

70 tidoglycan assembles at the pole of dividing Chlamydia trachomatis cells where daughter cell formatio

71 sex or symptoms is used to manage anorectal Chlamydia trachomatis (chlamydia) and Neisseria gonorrho

72 Chlamydia trachomatis conjunctivitis may present with ex

73 Chlamydia trachomatis (CT) and Mycoplasma genitalium (MG

74 hose who have not been diagnosed with rectal Chlamydia trachomatis (CT) and/or rectal Neisseria gonor

75 Rectal infections with Chlamydia trachomatis (CT) are prevalent in women visiti

76 The Chlamydia trachomatis (CT) bacterial load could have imp

77 cy, and infertility in women with a previous Chlamydia trachomatis (CT) diagnosis compared with women

78 Chlamydia trachomatis (Ct) has been associated with misc

79 The obligate-intracellular pathogen Chlamydia trachomatis (Ct) has undergone considerable ge

80 UU) was detected in 25 (17.2%) participants, Chlamydia trachomatis (CT) in 13 (9.0%), Mycoplasma geni

81 he diagnosis and management of uncomplicated Chlamydia trachomatis (CT) infection in adolescents and

82 Genital Chlamydia trachomatis (Ct) infection induces protective

83 n many districts and a considerable level of Chlamydia trachomatis (Ct) infection was evident.

84 study was to estimate the probability that a Chlamydia trachomatis (CT) infection will cause an episo

85 screening for Neisseria gonorrhoeae (NG) and Chlamydia trachomatis (CT) infections in all men who hav

86 Rectal Chlamydia trachomatis (CT) is common among clinic-attend

87 Chlamydia trachomatis (Ct) is the leading cause of bacte

88 The frequency and duration of Chlamydia trachomatis (Ct) ocular infections decrease wi

89 collected for Neisseria gonorrhoeae (GC) and Chlamydia trachomatis (CT) screening of HIV-1-infected M

90 extragenital Neisseria gonorrhoeae (NG) and Chlamydia trachomatis (CT) so universal extragenital sam

91 odel of HIV, Neisseria gonorrhoeae (NG), and Chlamydia trachomatis (CT) transmission dynamics among M

92 class Ic ribonucleotide reductase (RNR) from Chlamydia trachomatis (Ct) utilizes a Mn/Fe heterobinucl

93 Urine was tested for Chlamydia trachomatis (CT), Mycoplasma genitalium (MG),

94 Chlamydia trachomatis (CT), Mycoplasma genitalium (MG),

95 mSIBA) that allows simultaneous detection of Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG),

96 In the class Ic enzyme from Chlamydia trachomatis (Ct), the cysteine oxidant is the

97 An example is infection with Chlamydia trachomatis (Ct), which is the most common sex

98 We tested 30 potentially Chlamydia trachomatis (CT)-infected patients in a hospit

99 tercourse for Neisseria gonorrhoeae (GC) and Chlamydia trachomatis (CT).

100 extragenital Neisseria gonorrhoeae (NG) and Chlamydia trachomatis (CT).

101 Trachoma is caused by Chlamydia trachomatis (Ct).

102 The obligate intracellular pathogen Chlamydia trachomatis (Ctr) is a major cause of sexually

103 ured derivative of the human genital isolate Chlamydia trachomatis D/UW-3/Cx, strain CTD153, which al

104 Obligate intracellular bacteria such as Chlamydia trachomatis depend on metabolites of the host

105 Repeat Chlamydia trachomatis detection frequently occurs within

106 her probenecid would have a direct effect on Chlamydia trachomatis development through inhibition of

107 We examined the promoters for 10 Chlamydia trachomatis early genes and found that they co

108 We used a Chlamydia trachomatis elementary body (EB)-based enzyme-

109 Chlamydia trachomatis elementary body enzyme-linked immu

110 In contrast, the human pathogen Chlamydia trachomatis encodes only two nucleotide transp

111 bacter baumannii, Burkholderia pseudomallei, Chlamydia trachomatis, Escherichia coli, Klebsiella pneu

112 oring indicates an absence of infection with Chlamydia trachomatis even if FT persists, may be more c

113 erinary relatives, the oculogenital pathogen Chlamydia trachomatis evolved as a commensal organism of

114 o, the obligate intracellular human pathogen Chlamydia trachomatis exhibits elevated expression of a

115 Chlamydia trachomatis exits host epithelial cells throug

116 ancient neglected tropical disease caused by Chlamydia trachomatis for which a vaccine is needed.

117 Chlamydia trachomatis forms inclusions that are decorate

118 s for detection of Neisseria gonorrhoeae and Chlamydia trachomatis from pharyngeal and rectal specime

119 ances detection of Neisseria gonorrhoeae and Chlamydia trachomatis from rectal and pharyngeal sources

120 ancy and infertility observed in women after Chlamydia trachomatis genital infection result from asce

121 Chlamydia trachomatis genital tract infection is a major

122 fy novel transcriptional regulators from the Chlamydia trachomatis genome by predicting proteins with

123 The Chlamydia trachomatis genome encodes multiple bifunction

124 ncluding the obligate intracellular pathogen Chlamydia trachomatis, grow within a membrane-bound bact

125 The human pathogen Chlamydia trachomatis grows in a glycogen-rich vacuole.

126 .09, 0.66), and Neisseria gonorrhoeae and/or Chlamydia trachomatis had 92% lower odds of any adverse

127 The obligate intracellular parasite Chlamydia trachomatis has a reduced genome and is though

128 The obligate intracellular parasite Chlamydia trachomatis has a reduced genome but relies on

129 tive plasmid of both Chlamydia muridarum and Chlamydia trachomatis has been shown to control virulenc

130 We show that a LipL2 enzyme from Chlamydia trachomatis has similar activity, demonstratin

131 One such pathogen, Chlamydia trachomatis, has a limited capacity to synthes

132 hock proteins of the intracellular bacterium Chlamydia trachomatis have been associated with immune p

133 xiella burnetii, Listeria monocytogenes, and Chlamydia trachomatis have developed bipartite metabolis

134 Tests for ocular Chlamydia trachomatis have not been well characterized,

135 Chlamydia trachomatis (hazard ratio [HR], 3.14; 95% conf

136 atural infection induces partial immunity to Chlamydia trachomatis Identification of chlamydial antig

137 ltidomain type III secreted effector used by Chlamydia trachomatis In aggregate, existing data sugges

138 Repeated episodes of infection with Chlamydia trachomatis in childhood lead to severe conjun

139 is caused by recurrent ocular infection with Chlamydia trachomatis in childhood, with conjunctival sc

140 he prevalence of trachoma and infection with Chlamydia trachomatis in communities after 3-7 years of

141 Urogenital infection with Chlamydia trachomatis in some women can lead to upper ge

142 The epidemiology of Chlamydia trachomatis in the Middle East and north Afric

143 nts of the genetically intransigent pathogen Chlamydia trachomatis, in which all mutations have been

144 The immunopathogenesis of Chlamydia trachomatis-induced oviduct pathological seque

145 inflammatory mediator, ATP, is released from Chlamydia trachomatis-infected epithelial cells.

146 Women who tested positive for Chlamydia trachomatis infection after having been contac

147 ned whether TLR variants are associated with Chlamydia trachomatis infection among women with pelvic

148 nces about the true population prevalence of Chlamydia trachomatis infection and disease and the sens

149 A sensing directs IFN-beta expression during Chlamydia trachomatis infection and suggest that effecto

150 ate point-of-care (POC) diagnostic tests for Chlamydia trachomatis infection are urgently needed for

151 obiota in a cohort of 149 women with genital Chlamydia trachomatis infection at baseline who were fol

152 Conjunctival Chlamydia trachomatis infection causes scarring, entropi

153 witnessed a disturbing increase in cases of Chlamydia trachomatis infection despite enhanced control

154 served signs of trachomatous inflammation or Chlamydia trachomatis infection diagnosed using PCR.

155 ral discharge to diagnose N. gonorrhoeae and Chlamydia trachomatis infection in certain populations b

156 point of care test for detecting urogenital Chlamydia trachomatis infection in nonpregnant women and

157 Chlamydia trachomatis infection in the lower genital tra

158 Reproductive tract pathology caused by Chlamydia trachomatis infection is an important global c

159 The role of organism load in Chlamydia trachomatis infection is not well understood.

160 Chlamydia trachomatis infection is the most common bacte

161 Chlamydia trachomatis infection is the most common sexua

162 Chlamydia trachomatis infection is the most common sexua

163 Chlamydia trachomatis infection of the female genital tr

164 Chlamydia trachomatis infection of the human fallopian t

165 Urogenital Chlamydia trachomatis infection remains prevalent and ca

166 evaluated for trachoma, and determination of Chlamydia trachomatis infection was made.

167 ver, when LOS synthesis was inhibited during Chlamydia trachomatis infection, HeLa cells regained sus

168 w-up studies in a murine model of intranasal Chlamydia trachomatis infection, we analogously found th

169 d concern about efficacy of azithromycin for Chlamydia trachomatis infection.

170 ation of women notified by a sex partner for Chlamydia trachomatis infection.

171 We developed a ddPCR assay for Chlamydia trachomatis infections and found it to be accu

172 While Chlamydia trachomatis infections are frequently asymptom

173 ociated with pathological sequelae of ocular Chlamydia trachomatis infections in The Gambia.

174 Genital Chlamydia trachomatis infections in women typically are

175 ed to implement a vaccine to protect against Chlamydia trachomatis infections.

176 this study, we show that the human pathogen Chlamydia trachomatis infects the murine respiratory and

177 Chlamydia trachomatis is a bacterial pathogen causing oc

178 Chlamydia trachomatis is a genetically intractable oblig

179 The bacterial pathogen Chlamydia trachomatis is a global health burden currentl

180 Chlamydia trachomatis is a global health burden due to i

181 Chlamydia trachomatis is a Gram-negative obligate intrac

182 Although Chlamydia trachomatis is a human genital tract pathogen,

183 Chlamydia trachomatis is a leading cause of genital and

184 Chlamydia trachomatis is a medically important pathogen

185 Chlamydia trachomatis is a pathogen responsible for a pr

186 Chlamydia trachomatis is among the most clinically signi

187 Chlamydia trachomatis is an important human pathogen tha

188 Chlamydia trachomatis is an important risk factor for PI

189 Chlamydia trachomatis is an obligate intracellular bacte

190 Chlamydia trachomatis is an obligate intracellular bacte

191 Chlamydia trachomatis is an obligate intracellular bacte

192 Chlamydia trachomatis is an obligate intracellular epith

193 Chlamydia trachomatis is an obligate intracellular human

194 Chlamydia trachomatis is an obligate intracellular human

195 Chlamydia trachomatis is an obligate intracellular mucos

196 Chlamydia trachomatis is an obligate intracellular patho

197 Chlamydia trachomatis is an obligate intracellular patho

198 Chlamydia trachomatis is an obligate intracellular patho

199 Chlamydia trachomatis is an obligate intracellular patho

200 Chlamydia trachomatis is an obligate intracellular patho

201 Chlamydia trachomatis is considered the most common agen

202 The genital tract pathogen Chlamydia trachomatis is frequently detected in the gast

203 ar (TF) is common, but ocular infection with Chlamydia trachomatis is not.

204 The trp operon of Chlamydia trachomatis is organized differently from othe

205 current or long-term infections of humans by Chlamydia trachomatis is poorly understood.

206 Chlamydia trachomatis is responsible for both trachoma a

207 Chlamydia trachomatis is responsible for sexually transm

208 ween genital and ocular clinical isolates of Chlamydia trachomatis is that only the former express a

209 The obligate intracellular human pathogen Chlamydia trachomatis is the etiological agent of blindi

210 Chlamydia trachomatis is the leading cause of bacterial

211 Chlamydia trachomatis is the leading cause of infection-

212 The obligate intracellular pathogen Chlamydia trachomatis is the leading cause of noncongeni

213 Chlamydia trachomatis is the leading cause of sexually t

214 Chlamydia trachomatis is the leading infectious cause of

215 The obligate intracellular bacterium Chlamydia trachomatis is the most common cause of bacter

216 Chlamydia trachomatis is the most common notifiable dise

217 Chlamydia trachomatis is the most common sexually transm

218 Chlamydia trachomatis is the most common sexually transm

219 Chlamydia trachomatis is the most common sexually transm

220 Chlamydia trachomatis is the most common sexually transm

221 Chlamydia trachomatis is the most commonly reported bact

222 Chlamydia trachomatis is the world's most prevalent bact

223 a, caused by repeated infections with ocular Chlamydia trachomatis, is targeted for elimination using

224 aused by the obligate intracellular organism Chlamydia trachomatis, is the world's leading cause of p

225 Chlamydia trachomatis isolates that cause trachoma, sexu

226 Chlamydia trachomatis isolates were obtained before and

227 , increased the growth of the human pathogen Chlamydia trachomatis (L2) in wild-type murine fibroblas

228 pecifically bound and repressed promoters of Chlamydia trachomatis late genes, but not early or mid g

229 The VD4 region from the Chlamydia trachomatis major outer membrane protein conta

230 In some women, sexually transmitted Chlamydia trachomatis may ascend to infect the endometri

231 Sexually transmitted infection with Chlamydia trachomatis may lead to fibrotic blockage in w

232 Chlamydia muridarum and Chlamydia trachomatis mouse models of genital infection

233 dered idiopathic when Neisseria gonorrhoeae, Chlamydia trachomatis, Mycoplasma genitalium, Trichomona

234 assessed the intervention effect on incident Chlamydia trachomatis, Neisseria gonorrhoeae, and Mycopl

235 a, and first-void female urine specimens for Chlamydia trachomatis, Neisseria gonorrhoeae, and Tricho

236 sites were tested for M. genitalium and for Chlamydia trachomatis, Neisseria gonorrhoeae, and Tricho

237 s, the prevalences of Mycoplasma genitalium, Chlamydia trachomatis, Neisseria gonorrhoeae, and Tricho

238 Positivity rates for Chlamydia trachomatis, Neisseria gonorrhoeae, and Tricho

239 e new insights concerning the concurrence of Chlamydia trachomatis, Neisseria gonorrhoeae, Mycoplasma

240 uently drink alcohol and to be infected with Chlamydia trachomatis, Neisseria gonorrhoeae, or herpes

241 d for M. genitalium and other STI organisms (Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomona

242 Specimens were tested for M. genitalium, Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomona

243 ed with those for batches of 24 samples; for Chlamydia trachomatis/Neisseria gonorrhoeae tests, the a

244 rs) was significantly greater than those for Chlamydia trachomatis or N. gonorrhoeae (27.6 and 25.9 y

245 We previously reported that the Chlamydia trachomatis outer membrane complex protein B (

246 The Chlamydia trachomatis outer membrane complex protein B (

247 m, P = .04; HSV-2, P = .001; and a trend for Chlamydia trachomatis, P = .06).

248 ed on filter paper to test for antibodies to Chlamydia trachomatis pgp3 using a multiplex bead assay.

249 er paper and dried to test for antibodies to Chlamydia trachomatis pgp3 using the Luminex platform.

250 The Chlamydia trachomatis plasmid is a virulence factor.

251 ryngeal and rectal Neisseria gonorrhoeae and Chlamydia trachomatis play important roles in infection

252 Although the Chlamydia trachomatis protein Cta1 has been identified t

253 A new R2 subclass, R2c, prototyped by the Chlamydia trachomatis protein was recently discovered.

254 Comparator assays included BD ProbeTec Chlamydia trachomatis Q(x) (CTQ)/Neisseria gonorrhoeae Q

255 Chlamydia trachomatis remains a leading cause of bacteri

256 Obligate intracellular Chlamydia trachomatis replicate in a membrane-bound vacu

257 he bacterial obligate intracellular pathogen Chlamydia trachomatis replicates within a membrane-bound

258 The recent success in transformation of Chlamydia trachomatis represents a major advancement in

259 source, molecular Neisseria gonorrhoeae and Chlamydia trachomatis results, and relative light unit (

260 nd Mn(III)Fe(III) sites in the R2 subunit of Chlamydia trachomatis ribonucleotide reductase using x-r

261 The Mn(IV)/Fe(III) cofactor of Chlamydia trachomatis RNR assembles via a Mn(IV)/Fe(IV)

262 5 x 10(2) inclusion-forming units (IFUs) of Chlamydia trachomatis serovar D.

263 Chlamydia trachomatis serovar L2 and Chlamydia muridarum

264 cycle of the obligate intracellular pathogen Chlamydia trachomatis serovar L2 is controlled in part b

265 .) routes with recombinant MOMP (rMOMP) from Chlamydia trachomatis serovars D (UW-3/Cx), E (Bour), or

266 fections caused by Neisseria gonorrhoeae and Chlamydia trachomatis serovars D to K occur at high inci

267 Transformation of Chlamydia trachomatis should greatly advance the chlamyd

268 We now report that a Chlamydia trachomatis strain deficient in expression of

269 Previous studies identified specific Chlamydia trachomatis strains circulating among men who

270 The lack of resistance in Chlamydia trachomatis suggests that azithromycin might r

271 erive the intact structure of the primordial Chlamydia trachomatis T3SS in the presence and absence o

272 The human pathogen Chlamydia trachomatis targets epithelial cells lining th

273 id-based genetic transformation protocol for Chlamydia trachomatis that for the first time provides a

274 The obligate intracellular bacteria Chlamydia trachomatis, the causative agent of trachoma a

275 gnificantly reduces the prevalence of ocular Chlamydia trachomatis, the causative organism of trachom

276 or infertility (TFI) that is attributable to Chlamydia trachomatis, the population excess fraction (P

277 nd include the agent of oculogenital disease Chlamydia trachomatis, the respiratory pathogen C. pneum

278 d mice infected with Chlamydia muridarum and Chlamydia trachomatis to determine if there were differe

279 ating between-strain genomic recombinants of Chlamydia trachomatis to facilitate the organism's evolu

280 Examination of the ability of Chlamydia trachomatis to prevent neutrophil apoptosis in

281 address the potential for plasmid-deficient Chlamydia trachomatis to serve as a live attenuated vacc

282 ted, we purified and analyzed three putative Chlamydia trachomatis topoisomerases.

283 haracterization of a previously undocumented Chlamydia trachomatis transcription factor, designated G

284 cts of control strategies on the dynamics of Chlamydia trachomatis transmission are difficult to quan

285 pants were tested for Neisseria gonorrhoeae, Chlamydia trachomatis, Treponema pallidum (syphilis), he

286 seria gonorrhoeae, Streptococcus agalactiae, Chlamydia trachomatis, Trichomonas vaginalis, and Candid

287 The Chlamydia trachomatis type three-secreted effector prote

288 the lifetime was tested for the presence of Chlamydia trachomatis, type-specific human papillomaviru

289 Chlamydia trachomatis urogenital serovars replicate pred

290 e first, found in the intracellular pathogen Chlamydia trachomatis, uses YhhQ and tRNA guanine transg

291 nd to a common Ag in Chlamydia muridarum and Chlamydia trachomatis Using an adoptive-transfer approac

292 urine samples) for Neisseria gonorrhoeae and Chlamydia trachomatis using nucleic acid amplification t

293 ns with the obligate intracellular bacterium Chlamydia trachomatis, variation in immune activation an

294 nto the eukaryotic host cell is required for Chlamydia trachomatis virulence.

295 Chlamydia trachomatis was detected by the Amplicor PCR t

296 n a community with a high prevalence of STI, Chlamydia trachomatis was detected in 8.7% and Neisseria

297 An atypical response regulator, ChxR, from Chlamydia trachomatis, was previously reported to form h

298 Replicating Chlamydia trachomatis were labelled with these probes th

299 llowing repeated conjunctival infection with Chlamydia trachomatis, which causes a chronic inflammato

300 ndida albicans, Streptococcus agalactiae and Chlamydia trachomatis with a single biochip, enabling a